Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Merivaara AB
AB
Active
Org 5566160304
Karlsbodavägen 41, 168 67
Bromma
Wholesale of pharmaceutical and medical goods
·
NACE 4646
Est. 2001 · 24 years old
16 employees
Monitor
Share
Sweden
/
Companies
/
Wholesale of pharmaceutical and medical goods
/
Merivaara AB
Overview
Financials
People & ownership
Related companies
Loading company…
People & ownership
Management
Actively employed in the business
Name
Role
Member since
Current (2)
PM
Patrik Mikael Ekenberg
Chief Auditor
Chief Auditor
2021
AK
Anna Katarina Moëll
Chief Executive Officer
Chief Executive Officer
2025
Former (3)
VM
Vuokko Maaria Martin-Vivaldi
Chief Auditor
Chief Auditor
2022 – 2023
JS
Johan Stefan Juhlin
Chief Executive Officer
Chief Executive Officer
2021 – 2025
EM
Elin Maria Granlund
Chief Auditor
Chief Auditor
Board of directors
Non-executive oversight
Name
Role
Member since
Current (5)
JR
Juha Risto Einari Taimisto
Board of Directors
Board of Directors
2021
JA
Jari Antero Raudanpää
Board of Directors
Board of Directors
2026
AV
Antti Ville Tuomas Laine
Deputy Board Member
Deputy Board Member
2026
RQ
Roberto Quintero Brajcich
Board of Directors
Board of Directors
2026
TP
Tommi Petteri Salonen
Chairman
Chairman
2026
Former (2)
HI
Hans Ingvar Bredberg
Board of Directors
Board of Directors
2021 – 2022
SH
Sari-Johanna Hyvönen
Board of Directors
Board of Directors
2022 – 2024
Shareholders
As of last annual report
MERIVAARA OY — 100%
100%
Shareholder
Type
Ownership
Votes
Since
MERIVAARA OY
Company
100%
100%
2025
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
More on Merivaara AB
Overview →
Headline figures, risk assessment and company summary
Financials & key figures →
Revenue, EBITDA, balance sheet and 5-year trend
Related companies →
Corporate hierarchy, parent and subsidiary network
2022 – 2022